Avibactam dosage plays an important role in the successful treatment of multidrug-resistant gram-negative bacterial infections. Since avibactam is not administered alone, it is most commonly used in combination with ceftazidime to restore antibiotic activity against bacteria that produce beta-lactamase enzymes. Selecting the correct dose depends on several clinical factors, including the type of infection, kidney...Read More

Gram-negative bacteria are among the most clinically significant pathogens in modern medicine. They are responsible for a wide range of infections, from uncomplicated urinary tract infections (UTIs) to life-threatening bloodstream infections and hospital-acquired pneumonia. Over the past decade, the increasing prevalence of multidrug-resistant (MDR) gram-negative organisms has made treatment increasingly complex, posing a major challenge...Read More